The significant correlation between CSF VILIP-1 and cerebral glucose metabolism in CI participants indicates that VILIP-1 not only reflects the extent of neuronal injury but also predicts the rate of metabolic decline over time, which is a crucial manifestation in the clinical course of AD and other dementias [6]. Here, VSNL1 is linked to Alzheimer disease.